|
Main
|
|
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
|
Register:
|
ChiCTR |
|
Last refreshed on:
|
18 April 2017 |
|
Main ID: |
ChiCTR-IPR-14005315 |
|
Date of registration:
|
2014-09-04 |
|
Prospective Registration:
|
Yes |
|
Primary sponsor: |
|
|
Public title:
|
The effect of thrombosis aspiration combined ticagrelor on myocardial perfusion and prognosis of primary PCI for STEMI
|
|
Scientific title:
|
The effect of thrombosis aspiration combined ticagrelor on myocardial perfusion and prognosis of pr |
|
Date of first enrolment:
|
2014-09-11 |
|
Target sample size:
|
A:100;B:100;C:100; |
|
Recruitment status: |
Recruiting |
|
URL:
|
http://www.chictr.org.cn/showproj.aspx?proj=9633 |
|
Study type:
|
Interventional study |
|
Study design:
|
Randomized parallel controlled trial
|
|
Phase:
|
Post-market
|
|
|
Countries of recruitment
|
|
China
| | | | | | | |
|
Contacts
|
|
Name:
|
Yuhua Zhao
|
|
Address:
|
NO 1000, Dongguan Road, Nancheng district, Dongguan, Guangdong
|
|
Telephone:
|
+86 13549393086 |
|
Email:
|
zhao19661@163.com |
|
Affiliation:
|
|
|
|
Name:
|
Guoliang Jia
|
|
Address:
|
NO 1000, Dongguan Road, Nancheng district, Dongguan, Guangdong
|
|
Telephone:
|
+86 0769 22823333 |
|
Email:
|
jg173466@163.com |
|
Affiliation:
|
Kanghua Hospital |
| |
|
Key inclusion & exclusion criteria
|
Inclusion criteria: STEMI patients undergoing primary PCI.
Exclusion criteria: (1) hypersensitivity to asprin, tigeralor, heparin;
(2) who need to undergo emergency coronary artery bypass surgery;
(3) who has already received thrombolytic therapy; Save type PCI patients;
(4) Killip more than and equal to level III;
(5) Severe renal dysfunction, serum creatinine more than and equal to 3mg/dl
Age minimum:
18
Age maximum:
80
Gender:
|
|
Health Condition(s) or Problem(s) studied
|
|
ST segment elevation myocardial infarction
|
|
Intervention(s)
|
|
A:asprin+ticagrelor+heparin;B:asprin+ticagrelor+bivalirudin ;C:asprin+clopidogrel+heparin ;
|
|
Primary Outcome(s)
|
|
Electrocardiogram(ECG);Serum troponin T(cTnT);Serum creatine kinase(CK-MB);NT-proBNP;Measure left ventricular ejection fraction through;Measure infarction area through ultrasound angiogr;Bleeding complications of introperation and postop;The incidence of major adverse cardiovascular even;Reinfarction;Target vessel revascularization (TVR);
|
|
Source(s) of Monetary Support
|
|
Dongguan Kanghua Hospital Heart Center Sunshine Fund
|
|
Results
|
|
Results available:
|
|
|
Date Posted:
|
|
|
Date Completed:
|
|
|
URL:
|
|
|
|